Mediator kinase module proteins, genetic alterations and expression of super-enhancer regulated genes in colorectal cancer

Ioannis A. Voutsadakis
DOI: https://doi.org/10.1007/s43440-024-00589-2
2024-04-12
Pharmacological Reports
Abstract:Genetic alterations are well characterized as contributors to the pathogenesis of cancers. Epigenetic abnormalities can lead to perturbations of the expression of genes in cancer cells without structural defects. Deregulation of proteins of the transcription machinery may result in perturbations of target genes. Mediator, a multiprotein component of the transcription machinery facilitates the function of RNA polymerase II, which transcribes most human genes. A part of the mediator with kinase activity, called the Mediator kinase module shows genetic alterations in a sub-set of colorectal cancers.
pharmacology & pharmacy
What problem does this paper attempt to address?